Header Logo

Connection

ERIC SCHAFER to Microtubules

Back to Details
This is a "connection" page, showing publications ERIC SCHAFER has written about Microtubules.
ERIC SCHAFER
Connection Strength
0.146
Microtubules
  1. A phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314). Pediatr Blood Cancer. 2018 08; 65(8):e27066.
    View in: PubMed
    Score: 0.146
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.